Diclofenac Potassium
30 NDCs across 19 manufacturers|28 Generic,2 Brand
Diclofenac Potassium is used to treat juvenile arthritis, rheumatoid arthritis, dysmenorrhea, inflammation, keratosis and osteoarthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 24, 1993, and the first generic was approved Aug 6, 1998. FDA's Orange Book lists 22 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $90 million on Diclofenac Potassium across 376,000 claims for 161,000 beneficiaries.
Diclofenac Potassium is available as 30 NDCs from 19 manufacturers (28 generic, 2 brand), with NADAC prices from $0.11 to $94.43 per EA — the most expensive product costs about 840× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
30
28G / 2B
Manufacturers
19
competing in market
Price Spread
$0.11 – $94.43
per EA
7d Activity
avg +0.6% WoW · of 30 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Advagen Pharma Ltd. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Nonsteroidal Anti-inflammatory Drug class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
19 manufacturers producing DICLOFENAC POTASSIUM(1 pricing outlier)
Frequently Asked Questions
What is Diclofenac Potassium used to treat?
Diclofenac Potassium is used to treat juvenile arthritis, rheumatoid arthritis, dysmenorrhea, inflammation, keratosis and osteoarthritis, per the National Library of Medicine's MED-RT classification.
When did Diclofenac Potassium become available as a generic?
FDA approved the first generic Diclofenac Potassium (ANDA) on Aug 6, 1998. The Orange Book currently lists 22 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Diclofenac Potassium?
In 2024, Medicare Part D spent $90 million on Diclofenac Potassium across 376,000 claims for 161,000 beneficiaries.
How many Diclofenac Potassium products are on the market?
The Diclofenac Potassium drug market contains 30 NDCs from 19 manufacturers — 28 generic and 2 brand products.
What is the price range for Diclofenac Potassium?
NADAC reference prices for Diclofenac Potassium range from $0.1125 to $94.4349 per EA — the most expensive product costs about 840× the cheapest.
Is generic Diclofenac Potassium cheaper than brand?
The average generic NADAC for Diclofenac Potassium is $4.4221 per EA, versus $54.1057 for brand-labeled products — brand versions average about 12× the generic price.
Which manufacturers make Diclofenac Potassium?
19 manufacturers list Diclofenac Potassium in NADAC. Ranked by number of NDCs, the largest are Advagen Pharma Ltd. (3), Teva Pharmaceuticals USA Inc. (3), Assertio Therapeutics, Inc. (2), Leading Pharma, LLC (2), Camber Pharmaceuticals Inc. (2).
How has the price of Diclofenac Potassium changed recently?
Over the past 7 days, 21 Diclofenac Potassium NDCs rose and 7 fell, with a market-wide average change of +0.6%.